RunnerBox Encourages Parkinson’s Foundation’s Endurance Champions
The gift subscription service RunnerBox joined with the Parkinson’s Foundation to provide boxes filled with customized items for those…
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The gift subscription service RunnerBox joined with the Parkinson’s Foundation to provide boxes filled with customized items for those…
In the culmination of a woman’s 10-year campaign, the government of Ontario, Canada, has agreed to recognize Parkinson’s disease (PD)…
The Parkinson’s and Movement Disorder Center at the Queen’s Medical Center will use a $387,000 Michael J. Fox…
A Parkinson’s UK effort to bring greater racial and ethnic inclusivity to research into Parkinson’s disease is moving forward with…
To expand access to quality care, the Parkinson’s Foundation is expanding to 60 the Centers of Excellence within its Global Care Network for…
Aiming to improve the clinical outcomes of people with Parkinson’s disease, pharmaceutical company UCB is partnering with key…
To heighten awareness and understanding of nonmotor Parkinson’s disease symptoms such as hallucinations and delusions, Acadia Pharmaceuticals and…
Those attending The Michael J. Fox Foundation’s (MJFF) “A Funny Thing Happened on the Way to Cure Parkinson’s” annual…
A grant from the Parkinson Voice Project will be used to enhance the training and resources available to speech language pathologists…
Two established Parkinson’s disease (PD) treatments — Gocovri (amantadine) and Osmolex ER (amantadine hydrochloride) — will move to…
Get regular updates to your inbox.